Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jakob

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|April 30, 2003
Circulating hepatocyte growth factor levels in multiple myelomaChristian Jakob, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology|August 22, 2003
Bisphosphonates in early multiple myelomaOrhan Sezer, Christian Jakob, Ivana Zavrski, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Molecular and clinical aspects of proteasome inhibition in the treatment of cancerIvana Zavrski, Christian Jakob, Martin Kaiser, et al.
Biochemical and Biophysical Research Communications|October 12, 2005
Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone diseaseUlrike Heider, Lorenz C Hofbauer, Ivana Zavrski, et al.
British Journal of Haematology|October 3, 2002
Serum levels of VEGF do not correlate with the severity of multiple myelomaChristian Jakob, Ivana Zavrski, Ulrike Heider, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
Bone markers in multiple myelomaUlrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
Experimental Cell Research|May 5, 2009
Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myelomaIvana von Metzler, Ulrike Heider, Maren Mieth, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2006
Angiogenesis in multiple myelomaChristian Jakob, Jan Sterz, Ivana Zavrski, et al.
Blood|June 18, 2002
Immunocytochemistry reveals RANKL expression of myeloma cellsOrhan Sezer, Ulrike Heider, Christian Jakob, et al.
European Journal of Haematology|July 21, 2009
Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patientsMartina Kleber, Gabriele Ihorst, Barbara Deschler, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|April 30, 2003
Circulating hepatocyte growth factor levels in multiple myelomaChristian Jakob, Claudia Fleissner, Ivana Zavrski, et al.
European Journal of Haematology|August 22, 2003
Bisphosphonates in early multiple myelomaOrhan Sezer, Christian Jakob, Ivana Zavrski, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Molecular and clinical aspects of proteasome inhibition in the treatment of cancerIvana Zavrski, Christian Jakob, Martin Kaiser, et al.
Biochemical and Biophysical Research Communications|October 12, 2005
Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone diseaseUlrike Heider, Lorenz C Hofbauer, Ivana Zavrski, et al.
British Journal of Haematology|October 3, 2002
Serum levels of VEGF do not correlate with the severity of multiple myelomaChristian Jakob, Ivana Zavrski, Ulrike Heider, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2006
Bone markers in multiple myelomaUlrike Heider, Claudia Fleissner, Ivana Zavrski, et al.
Experimental Cell Research|May 5, 2009
Synergistic interaction of proteasome and topoisomerase II inhibition in multiple myelomaIvana von Metzler, Ulrike Heider, Maren Mieth, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2006
Angiogenesis in multiple myelomaChristian Jakob, Jan Sterz, Ivana Zavrski, et al.
Blood|June 18, 2002
Immunocytochemistry reveals RANKL expression of myeloma cellsOrhan Sezer, Ulrike Heider, Christian Jakob, et al.
European Journal of Haematology|July 21, 2009
Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patientsMartina Kleber, Gabriele Ihorst, Barbara Deschler, et al.
Pageof 5